Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
VIR compared with LYEL: revenue, margins and what each company keeps, and the suppliers and customers both name
VIR
Vir Biotechnology, Inc.
Change
Mkt cap
Revenue
Revenue
LYEL
Lyell Immunopharma, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
VIR
Vir Biotechnology, Inc.
vs
LYEL
Lyell Immunopharma, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
VIR
Vir Biotechnology, Inc.
Change
11.05
▼
−2.19%
Mkt cap
$1.9B
Revenue
$239M
Q2 FY26
Revenue
$74M
FY24
LYEL
Lyell Immunopharma, Inc.
Change
11.11
▲
+0.63%
Regular session
Sep 2 '83
Mkt cap
$270.5M
Revenue
$4,000
Q2 FY26
Revenue
$36,000
FY25
vs
Compare
Regular session
Sep 2 '83
VIR
Vir Biotechnology, Inc.
vs
LYEL
Lyell Immunopharma, Inc.
11.05
▼
−2.19%
Price
11.11
▲
+0.63%
$1.9B
Mkt cap
$270.5M
Q2 FY26
$239M
Revenue
$4,000
Q2 FY26
FY24
$74M
Revenue
$36,000
FY25
Change
Change
VIR
11.05
▼
−2.19%
vs
LYEL
11.11
▲
+0.63%
Regular session
Sep 2 '83
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
LYEL: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only VIR
8
ALNY
Alnylam
supplier
XNCR
Xencor
supplier
SNY
Sanofi
supplier
—
Astellas
unlisted
customer
4 more · VIR chain
›
Shared
0
No shared counterparties.
Only LYEL
11
—
City of Hope Comprehensive Cancer Center
unlisted
supplier
—
Dana Farber Cancer Institute
unlisted
supplier
—
Innovative Cellular Therapeutics Holdings Limited and Innovative Cellular Therapeutics, Inc. (together, ICT)
unlisted
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
supplier
—
Miltenyi CliniMACS PRODIGY ®
unlisted
supplier
7 more · LYEL chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
VIR, solid
LYEL, dashed